NEW YORK CITY, NEW YORK / ACCESS Newswire / May 16, 2025 / Bionoid Pharma Inc. (OTC PINK:BINP) proudly announces its corporate rebranding to AI Maverick Intel, Inc., marking a significant transformation in its strategic direction. This change underscores the company’s commitment to leveraging advanced artificial intelligence technologies to revolutionize customer acquisition and engagement across healthcare, biotech, and other sectors.
The rebranding follows the successful acquisition of AI Maverick Intel, a leading platform renowned for its proprietary AI solutions that automate and enhance audience engagement. The platform’s capabilities enable intelligent, two-way communication and data-driven interactions, positioning the company at the forefront of AI-driven business solutions.
“Our evolution into AI Maverick Intel, Inc. signifies more than a name change; it represents our dedication to pioneering AI technologies that drive meaningful engagement and sustainable growth,” said Wayne Cockburn, CEO of AI Maverick Intel, Inc. “By integrating cutting-edge AI solutions, we are poised to deliver unparalleled value to our clients and stakeholders.”
The company’s flagship AI Maverick platform is designed to streamline customer acquisition processes, enabling businesses to identify, reach, and engage their target audiences with unprecedented efficiency and precision. This strategic shift aligns with the company’s vision to become a leader in AI-driven solutions that foster innovation and long-term value creation.
For more information about AI Maverick Intel, Inc. and its innovative AI solutions, please visit https://aimaverickintel.com/
About Bionoid Pharma Inc.
Bionoid Pharma Inc. is a growth-oriented AI company focused on acquiring and enhancing revenue-generating businesses through its proprietary AI Maverick platform. The technology enables intelligent, two-way communication and data-driven engagement across healthcare, biotech, and other sectors. Bionoid aims to deliver long-term value through innovation, efficiency, and strategic partnerships.
Stay Connected:
Website | AI Maverick | OTC:BINP | X: @BionoidPharminc
Media Contact:
Wayne Cockburn, CEO
(905) 505-0770
Email: bionoidpharma@gmail.com
SOURCE: Bionoid Pharma Inc.
View the original press release on ACCESS Newswire
Ten years after the veteran nonprofit was founded, the woman it once served will lead…
Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic…
SOBR Provides Clarity and Considers Future Options DENVER, CO / ACCESS Newswire / October 2,…
Every Detail Matters: MagnaFlow Helps Put the Finishing Touch on Project REBORN's 5-Inch Exhaust NORTH…
CEO David Antelo outlines a new path focused on technology validation, smaller facilities and domestic…
The sale of Holly View Apartments reflects founder and CEO Raphael Toledano's disciplined approach to…